68Ga-PSMA-11 PET/CT Versus Conventional Imaging for Response Evaluation in Metastatic Castration-resistant Prostate Cancer
PCWG3 remains the most effective response criterion overall and for ARPI-treated patients, while RECIP-1.0 showed better prognostic value for non-ARPI patients. Larger studies are needed to validate these findings.
Authors
- Harmandeep Singh (ORCID: https://orcid.org/0000-0003-0997-7777)
- Shikha Goyal (ORCID: https://orcid.org/0000-0002-9972-6682)
- Ashwani Sood (ORCID: https://orcid.org/0000-0001-7228-0361)
- Gaurav Prakash (ORCID: https://orcid.org/0000-0002-1505-8024)
- Komal Preet (ORCID: https://orcid.org/0009-0007-4819-5547)
- B. R. Mittal
- Priyavrat Purohit
- Ravimohan Mavuduru
- Piyush Aggarwal
- Pritika Dhiman
- Swayamjeet Satapathy
Institutions
- Tata Memorial Hospital (IN)
- Therapeutics Clinical Research (US)
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1097/rlu.0000000000006147
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00